RecruitingNCT06814574
Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement - Single Center Experience
Sponsor
Deutsches Herzzentrum Muenchen
Enrollment
25 participants
Start Date
Jan 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Eligibility
Inclusion Criteria1
- Transcatheter Tricuspid Valve Replacement
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06814574
Related Trials
Efficacy and Safety of Micra AV2 Transcatheter Pacing System
NCT073565051 location
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NCT071405621 location
Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment
NCT068775203 locations